Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
Clindove Research LLC · NCT07106879
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 7000
- US sites recruiting
- 1
- Study start
- July 30, 2025
- Record last updated
- August 12, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
DOVE-MET-COME-100 is a single site prescreening survey study designed to identify adults who may be eligible for future industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, current health conditions and symptoms. The study team may also collect basic health information, including vital signs, urine drug tests, blood samples and pregnancy tests (if applicable). A physician will review each participant's medical history in a one-on-one interview to assess potential fit for upcoming trials. If needed, the doctor may contact the participant's current doctors or pharmacies to gather more information for eligibility review.
Being studied: Blood Work
Conditions: Cardiovascular Diseases; Metabolic Syndrome; Obesity; Prediabetes; Mental Health Disorders; Endocrine Dysfunction; Type 2 Diabetes Mellitus (T2DM); Chronic Kidney Disease (CKD)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Any participant of age 18 years and over
- Who are willing to provide informed consent and participate in the pre-screening study and comply with study procedures.
Exclusion Criteria
- Pregnant or breastfeeding individuals
- Individuals having severe cognitive impairment or inability to provide informed consent
- Individuals having acute psychiatric emergencies requiring immediate intervention/hospitalization
- Individuals who are currently participating in another research study that conflicts with pre-screening data collection
- Individuals having known history of drug/alcohol misuse
- Individuals having medical conditions that, in the investigator's opinion, could compromise the integrity of the screening process or pose significant risks to the participant's health.
Recruiting US locations
Clindove Research LLC
Brooklyn, NY 11221
Site contact: Nelly Cohen, MD · 516-518-3239 · study@clindoveresearch.com
Study contacts (from the official record)
- Nelly Cohen, MD · 516-518-3239 · study@clindoveresearch.com
Similar studies in New York
All weight loss studies in New York →- RecruitingHealthy volunteersPhase 1
Alpelisib Challenge Test (ACT)
Columbia University
- Location
- New York, NY
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1
Human Models of Selective Insulin Resistance: Alpelisib, Part I
Columbia University
- Location
- New York, NY
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- The Bronx, NY + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingHealthy volunteers
Hunger Perception and Weight-Related Outcomes Following Use of a Leptin-Supporting Dietary Supplement
Efforia, Inc
- Location
- New York, NY
- Eligibility basics
- Ages 18+